life science

A new computational method allows the detection, within just a few hours, of the genetic alterations responsible for the formation and progression of cancer tumours. This new method manages to accurately identify almost all types of genetic changes of cancer cells in a simple, quick and precise way. It is also able to identify large-scale chromosome rearrangements, which had been difficult to be detect until this breakthrough. The new method, called SMUFIN, has been developed by the Barcelona Supercomputing Centre and the ICREA (Catalan Institution of Research and Advanced Studies), in collaboration with research groups from Barcelona, Oviedo and Heidelberg. This progress has been published by the prestigious journal 'Nature Biotechnology' and represents a significant step forward towards the personalised treatment of cancer and other illnesses.

On Wednesday the World Health Organisation (WHO) appointed Barcelona-based researcher Pedro Alonso as the new Director of its Global Malaria Program. Alonso is a key figure in the global fight against malaria and has lead research into a vaccine to combat the life-threatening illness. He has been involved with WHO since 2011, when the organisation appointed him as the Chair of the GTS Steering Committee on the Global Technical Strategy on Malaria. Alonso is currently the Director of the Barcelona Institute for International Health Research. He is also the Head of the Department of International Health and Tropical Medicine at Barcelona's Hospital Clínic and a lecturer at Barcelona University. The physician is due to start his new position in October and is expected to give his formal recommendation on the strategy against malaria in the first quarter of 2015.

Catalonia has established a reputation as a global centre of scientific excellence, pioneering research and innovative ideas. This corner of Europe, with just 0.1% of the world’s population, accounts for nearly 1% of global scientific production. The Catalan Research system, formed of 12 internationally esteemed universities, over 60 research centres, 15 world class hospitals, and almost 9,000 innovative companies, attests to the Catalonia's ambitions in science. This territory is also a magnet of international funding: with 1.5% of Europe’s population, it receives 2.2% of European competitive funds and 3.5% of European Research Council (ERC) grants. There can be no doubt that Catalonia is now a benchmark in Southern Europe, producing frontier research and punching considerably above its weight in terms of scientific contribution.  It is attracting worldwide talent and projects, and many consider it to be fast becoming the Palo Alto of biomedical research.